[HTML][HTML] Sensitive periods of substance abuse: Early risk for the transition to dependence
CJ Jordan, SL Andersen - Developmental cognitive neuroscience, 2017 - Elsevier
Early adolescent substance use dramatically increases the risk of lifelong substance use
disorder (SUD). An adolescent sensitive period evolved to allow the development of risk …
disorder (SUD). An adolescent sensitive period evolved to allow the development of risk …
Experience during adolescence shapes brain development: From synapses and networks to normal and pathological behavior
Adolescence is a period of dramatic neural reorganization creating a period of vulnerability
and the possibility for the development of psychopathology. The maturation of various neural …
and the possibility for the development of psychopathology. The maturation of various neural …
Long-term voluntary wheel running is rewarding and produces plasticity in the mesolimbic reward pathway
BN Greenwood, TE Foley, TV Le, PV Strong… - Behavioural brain …, 2011 - Elsevier
The mesolimbic reward pathway is implicated in stress-related psychiatric disorders and is a
potential target of plasticity underlying the stress resistance produced by repeated voluntary …
potential target of plasticity underlying the stress resistance produced by repeated voluntary …
[HTML][HTML] Stress, sensitive periods, and substance abuse
SL Andersen - Neurobiology of stress, 2019 - Elsevier
Research on the inter-relationship between drug abuse and social stress has primarily
focused on the role of stress exposure during adulthood and more recently, adolescence …
focused on the role of stress exposure during adulthood and more recently, adolescence …
Neurobehavioral changes arising from early life dopamine signaling perturbations
LB Areal, RD Blakely - Neurochemistry international, 2020 - Elsevier
Dopamine (DA) signaling is critical to the modulation of multiple brain functions including
locomotion, reinforcement, attention and cognition. The literature provides strong evidence …
locomotion, reinforcement, attention and cognition. The literature provides strong evidence …
Enduring effects of adolescent ketamine exposure on cocaine-and sucrose-induced reward in male and female C57BL/6 mice
I Garcia-Carachure, FJ Flores-Ramirez… - …, 2020 - nature.com
Ketamine has shown promising antidepressant efficacy for adolescent treatment-resistant
depression. However, the potential enduring consequences of ketamine exposure have not …
depression. However, the potential enduring consequences of ketamine exposure have not …
Addiction-related gene regulation: Risks of exposure to cognitive enhancers vs. other psychostimulants
H Steiner, V Van Waes - Progress in neurobiology, 2013 - Elsevier
The psychostimulants methylphenidate (Ritalin, Concerta), amphetamine (Adderall), and
modafinil (Provigil) are widely used in the treatment of medical conditions such as attention …
modafinil (Provigil) are widely used in the treatment of medical conditions such as attention …
Behavioral, neurochemical and developmental effects of chronic oral methylphenidate: a review
D Senior, R Ahmed, E Arnavut, A Carvalho… - Journal of Personalized …, 2023 - mdpi.com
The majority of animal studies on methylphenidate (MP) use intraperitoneal (IP) injections,
subcutaneous (SC) injections, or the oral gavage route of administration. While all these …
subcutaneous (SC) injections, or the oral gavage route of administration. While all these …
Methylphenidate amplifies the potency and reinforcing effects of amphetamines by increasing dopamine transporter expression
Methylphenidate (MPH) is commonly diverted for recreational use, but the neurobiological
consequences of exposure to MPH at high, abused doses are not well defined. Here we …
consequences of exposure to MPH at high, abused doses are not well defined. Here we …
[HTML][HTML] Fluoxetine potentiates methylphenidate-induced behavioral responses: enhanced locomotion or stereotypies and facilitated acquisition of cocaine self …
L Lamoureux, JA Beverley, M Marinelli, H Steiner - Addiction neuroscience, 2023 - Elsevier
The medical psychostimulant methylphenidate (MP) is used to treat attention-deficit
hyperactivity disorder and recreationally as a “cognitive enhancer”. MP is a dopamine …
hyperactivity disorder and recreationally as a “cognitive enhancer”. MP is a dopamine …